This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Seattle Children's Hospital, Fred Hutchinson Cancer Center, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 89 
1 out of 309 
1 out of 3,697 
Years Active: 2024-2026
Title: Sihoun Hahn: Innovator in Newborn Screening Technologies
Introduction
Sihoun Hahn is a notable inventor based in Clyde Hill, WA (US). He has made significant contributions to the field of newborn screening, particularly in the detection of various genetic disorders. With a total of 3 patents, his work focuses on improving patient outcomes through early diagnosis.
Latest Patents
Hahn's latest patents include groundbreaking methods for newborn screening for primary immunodeficiencies, cystinosis, and Wilson disease. This innovative screening technique utilizes dried blood spots collected at birth to detect these potentially fatal disorders early on. Early detection is crucial, as it can significantly enhance patient outcomes before symptoms manifest.
Another important patent involves proteomic screening for lysosomal storage diseases (LSDs), including Mucopolysaccharidosis Type I (MPS I) and Pompe Disease. This method allows for the early identification of these diseases using biological samples such as dried blood spots, buccal swabs, and white blood cells. The disclosed methods not only improve early detection but also help predict a patient's immune response to enzyme replacement therapy, thereby enhancing treatment efficacy.
Career Highlights
Throughout his career, Sihoun Hahn has worked with esteemed institutions such as Seattle Children's Hospital and Fred Hutchinson Cancer Research Center. His work in these organizations has contributed to advancements in pediatric healthcare and genetic research.
Collaborations
Hahn has collaborated with notable colleagues, including Christopher Collins and Remwilyn Dayuha. These partnerships have fostered innovation and development in the field of newborn screening.
Conclusion
Sihoun Hahn's contributions to newborn screening technologies have the potential to save lives through early detection of serious genetic disorders. His innovative patents and collaborations highlight the importance of research in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile